Morgan Stanley PE acquires health functional foods maker Life & Bio Latest deal marks PE firm's first buyout investment since 2014
Translated by Kim So-in 공개 2022-04-07 08:11:14
이 기사는 2022년 04월 07일 08:09 thebell 에 표출된 기사입니다.
Morgan Stanley Private Equity (Morgan Stanley PE) will acquire South Korean health functional foods manufacturer Life & Bio, which will mark the firm’s first buyout investment in eight years.Morgan Stanley PE signed a stock purchase agreement to acquire management rights and new shares in Life & Bio, according to industry sources on Tuesday. The deal size is about 80 billion won ($65 million), which will be financed through the PE firm’s existing fund.
Life & Bio plans to use some of the proceeds to acquire baby food manufacturer Food Care. The deal will help Morgan Stanley PE to expand its portfolio of health functional food manufacturers ranging from infants to the elderly.
Life & Bio, which was established in 2016, has expanded its business into the food and beauty sectors. It recorded revenue of 10 billion won in 2018, just two years after its establishment.
Morgan Stanley PE has reportedly made the latest investment amid increasing demand for health functional foods after the Covid-19 pandemic. The PE firm plans to increase Life & Bio’s market share by expanding functional food brands targeting millennials and Generation Z after the acquisition.
The latest deal will mark Morgan Stanley PE’s first buyout in eight years after its takeover of Hanwha L&C, now Hyundai L&C, in 2014. The PE firm’s portfolio companies include Nolboo and Jeonju Paper. (Reporting by Byung-keun Kam)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
- 모간스탠리PE, 라이프앤바이오 인수...8년 만에 바이아웃 재개
- '메가딜 위력' 모간스탠리, 1위 수성…딜로이트안진 맹추격
- 모간스탠리PE, F&B기업 인수 추진…놀부 활로 찾나
- Morgan Stanley tops M&A advisor league table in first quarter
- Praxis Capital acquires management rights of health supplement firm SeungMyeong
- TPG to take final offers for Health Balance next month
- Prime Living & Health seeks a buyer
best clicks
최신뉴스 in 전체기사
-
- 우리금융 "롯데손보 M&A, 과도한 가격 부담 안한다"
- 신한캐피탈, 지속성장 포트폴리오 리밸런싱 체계 강화
- 하나금융, ELS 악재에도 실적 선방…확고한 수익 기반
- 하나금융, 자본비율 하락에도 주주환원 강화 의지
- 국민연금, '역대 최대 1.5조' 출자사업 닻 올렸다
- [도전 직면한 하이브 멀티레이블]하이브, 강한 자율성 보장 '양날의 검' 됐나
- [퍼포먼스&스톡]꺾여버린 기세에…포스코홀딩스, '자사주 소각' 카드 재소환
- [퍼포먼스&스톡]LG엔솔 예견된 실적·주가 하락, 비용 절감 '집중'
- [퍼포먼스&스톡]포스코인터, 컨센서스 웃돌았지만 주가는 '주춤'
- 신한금융, ‘리딩금융’ 재탈환에 주주환원 강화 자신감